The first batch of national centralized drug procurement
1,2018, 1 1. The pilot areas of centralized drug procurement organized by the state are: Beijing, Tianjin, Shanghai, Chongqing, Shenyang, Dalian, Xiamen, Guangzhou, Shenzhen, Chengdu and Xi 'an (referred to as1/kloc).
20 18 12: the purchase result of "4+7" included 25 drugs, 23 domestic drugs and 2 foreign drugs.
Source: Rong Yun database.
2. From September, 2065438 to September, 2009, 25 provinces and Xinjiang Production and Construction Corps participated in the pilot program of expanding centralized drug procurement and use organized by the state (four municipalities directly under the Central Government have participated in the "4+7" pilot program, and Fujian and Hebei provinces have followed up the pilot program on their own), and the scope of the pilot program has been expanded to the whole country. This centralized procurement involves the first batch of 25 kinds of winning products such as atorvastatin oral sustained-release dosage forms. The second batch of national drug quantity procurement was officially launched. The varieties selected in this centralized procurement are the same as the 25 Zhong Zhongbiao products purchased in 4+7 quantities.
The first batch of centralized drugs
3. The second batch of national centralized drug procurement: February 20 19, 19, the state announced the catalogue of domestic centralized drug procurement, with a total of ***33 varieties. Officially launched the second batch of national centralized drug procurement. In the official announcement of June 65438+1October 2 1 day, 2020, 32 of the 33 varieties were successfully purchased, * * * 100 products were selected, 122 companies participated, and finally 77 companies were selected.
The second batch of centralized medication
4. The third batch of centralized national drug procurement: On July 29, 2020, the document published a new round of centralized national drug procurement catalogue with 56 varieties, which officially opened the third batch of centralized national drug procurement. In the announcement at the end of August of the same year, it was learned that 55 of the 56 varieties were successfully purchased.
Centralized procurement of the third batch of drugs
5. The fourth batch of national centralized drug procurement: 202 1, 1 was announced, and 45 varieties were purchased in this batch. In February of the same year, the fourth batch of 45 kinds of drugs were all purchased successfully, and 152 enterprises participated in this centralized purchase. Selected enterprises 1 18, selected products 158, among which 5 foreign-funded enterprises selected 5 products.
Centralized procurement of the fourth batch of drugs
6. The fifth batch of national centralized drug procurement: In June, 20021year, the fifth batch of national centralized drug procurement required 62 varieties, and the data of that month was released. In the sixth batch of drugs, 62 varieties and 6/kloc-0 products were successfully purchased. According to statistics, 355 products from 20/kloc-0 companies participated in the bidding, with 6544 products. Among them, 10 foreign-funded enterprises 1 1 products were selected, and 138 domestic-funded enterprises 240 products were selected. The number of enterprises selected by foreign investors is the largest in previous centralized procurement. This centralized procurement involves 55 billion yuan, which is the highest in previous centralized procurement.
Centralized procurement of the fifth batch of drugs
7. The sixth batch of national centralized drug procurement mainly involves six categories 16 insulin varieties.
Centralized procurement of the sixth batch of drugs
The specific data of centralized collection of drugs can be queried in the drug financing cloud, and each batch, drug and pharmaceutical company can be analyzed.